Open-Chest Device Closure For The Minimally Invasive Management Of Atrial Septal Defect In Young Children

Hao Zhang,Shou-jun Li,Yong-qing Li,Hao Wang,Sheng-shou Hu
DOI: https://doi.org/10.1532/HSF98.20061179
2007-01-01
Abstract:Background. We integrated a catheter-based device and minimally invasive surgical techniques for the treatment of atrial septal defect for children younger than 2 years old.Methods. Forty-three patients were divided into 3 groups: group A underwent open-chest device closure with a right lateral thoracotomy (n = 12), group B underwent openheart repair with a right lateral thoracotomy and cardiopulmonary bypass ( n = 11), and group C underwent open-heart repair with a median thoracotomy and cardiopulmonary bypass ( n = 20).Results. Group A had the lowest weight ( 9.25 +/- 1.3 kg) and smallest defect size (10.25 +/- 3.9 mm). In group A, 2 patients had to be transitioned to open-heart repair after unsuccessful occlusion. Compared with the open-heart groups, the device group had a shorter total operation time ( 111 +/- 39 minutes), required the minimum amount of blood products ( 39 (+/-) 38 mL), and had a smaller amount of pleural drainage in the first 12 hours after the procedure ( 29 +/- 12 mL). All patients were discharged. The right ventricular end-diastolic diameter reduced significantly after the repair; furthermore, there was no difference in the size of reduction. However, the device group had the highest medical costs ( 30,639 +/- 3831 Chinese yuan). During the follow-up, there were no occluder-related complications observed in Group A, and there were no residual shunts or arrhythmia observed in the groups.Conclusions. The open-chest device closure was safely performed as a supplement for percutaneous treatment for young children.
What problem does this paper attempt to address?